National Cancer Institute Cancer Treatment Tolerability Consortium: Current status and future directions
As cancer treatments evolve, there is a growing need to assess, analyze, and integrate measurements of cancer treatment tolerability. This report describes the rationale, development, and outcomes of the National Cancer Institute Cancer Treatment Tolerability Consortium, and discusses future opportunities for cancer treatment tolerability research.
Authors
- Sandra A. Mitchell (ORCID: https://orcid.org/0000-0002-4153-9972)
- Rachel D. Altshuler (ORCID: https://orcid.org/0000-0002-1771-9287)
- Lori M. Minasian
- Alice P. Chen (ORCID: https://orcid.org/0000-0002-1426-853X)
- Diane St. Germain (ORCID: https://orcid.org/0000-0003-0399-5579)
- Brennan Parmelee Streck (ORCID: https://orcid.org/0000-0001-7033-1372)
Institutions
- National Institutes of Health (US)
- National Cancer Institute (US)
- Kelly Services (United States) (US)
Publication Details
- Journal
- Cancer
- Published
- 2025-10-15
- DOI
- https://doi.org/10.1002/cncr.35946
- Primary Topic
- Health Systems, Economic Evaluations, Quality of Life
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- U.S. Department of Health and Human Services
- National Institutes of Health
- National Cancer Institute